Literature DB >> 14534073

Control of LH secretory-burst frequency and interpulse-interval regularity in women.

Daniel M Keenan1, William S Evans, Johannes D Veldhuis.   

Abstract

Hypothalamic neurons generate discrete bursts of gonadotropin-releasing hormone (GnRH) and thereby pulses of luteinizing hormone (LH) at randomly timed intervals centered on a probabilistic mean frequency. We tested the hypothesis that physiological mechanisms govern not only the number but also the stochastic dispersion of the GnRH/LH pulse-renewal process in humans; for example, in young women in the early (EF) and late (LF) follicular and midluteal (ML) phases of the menstrual cycle (n = 18) and in postmenopausal individuals (PM, n = 16). To this end, we quantify stochastic interpulse variability by way of the order-independent, two-parameter Weibull renewal process (Keenan DM and Veldhuis J. Am J Physiol Regul Integr Comp Physiol 281: R1917-R1924, 2001) and the sequence-specific, model-free approximate-entropy statistic (ApEn) (Pincus SM. Proc Natl Acad Sci USA 88: 2297-2301, 1991). Statistical testing unveiled 1) reduced probabilistic mean LH secretory-burst frequency (lower lambda of the Weibull distribution) in ML compared with each of EF, LF, and PM (P < 0.001); 2) quantifiably more regular LH interburst-interval sets (elevated gamma of the Weibull density) in PM than in each of EF, LF, and ML (P < 0.01); 3) uniquely prolonged latency to maximal LH secretion within individual secretory bursts in ML (P < 0.01); and 4) comparably mean random, sequential LH interburst-interval and mass values (normalized ApEn) among the distinct hormonal milieus. From these data, we postulate that sex steroids and age determine daily LH secretory-burst number, quantifiable pulse-renewal variability, and secretory-waveform evolution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534073     DOI: 10.1152/ajpendo.00133.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  9 in total

1.  Age disrupts androgen receptor-modulated negative feedback in the gonadal axis in healthy men.

Authors:  Johannes D Veldhuis; Paul Y Takahashi; Daniel M Keenan; Peter Y Liu; Kristi L Mielke; Suanne M Weist
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-03       Impact factor: 4.310

Review 2.  Pulsatility of Hypothalamo-Pituitary Hormones: A Challenge in Quantification.

Authors:  Daniel M Keenan; Johannes D Veldhuis
Journal:  Physiology (Bethesda)       Date:  2016-01

Review 3.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

Review 4.  Changes in pituitary function with ageing and implications for patient care.

Authors:  Johannes D Veldhuis
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

5.  Bayesian analysis improves pulse secretion characterization in reproductive hormones.

Authors:  Huayu Liu; Alex J Polotsky; Gary K Grunwald; Nichole E Carlson
Journal:  Syst Biol Reprod Med       Date:  2017-12-29       Impact factor: 3.061

Review 6.  The menopause and aging, a comparative perspective.

Authors:  Caleb E Finch
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-10       Impact factor: 4.292

7.  Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men.

Authors:  Johannes D Veldhuis; Daniel M Keenan
Journal:  Eur J Endocrinol       Date:  2008-08-14       Impact factor: 6.664

8.  A comparison of methods for analyzing time series of pulsatile hormone data.

Authors:  N E Carlson; K W Horton; G K Grunwald
Journal:  Stat Med       Date:  2013-06-21       Impact factor: 2.373

9.  Dynamic Pituitary-Adrenal Interactions in the Critically Ill after Cardiac Surgery.

Authors:  Ben Gibbison; Daniel M Keenan; Ferdinand Roelfsema; Jon Evans; Kirsty Phillips; Chris A Rogers; Gianni D Angelini; Stafford L Lightman
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.